Mereo BioPharma Group plc
MREONASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $46.19M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.20$2.37
- Volume (live)
- -
- Avg. volume (3M)
- 1.57M
Mereo BioPharma Group (MREO) Stock Price & Financial Analysis
Mereo BioPharma Group Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.28 - $0.29 |
|---|---|
| 52-Week High | $2.37 |
| 52-Week Low | $0.20 |
| Open | $0.29 |
| Volume (last close) | 383.99K |
| Average Volume (3M) | 1.57M |
| 50-Day MA | $0.31 |
|---|---|
| 200-Day MA | $0.34 |
| 1-Year Change | −85.63% |
| Market Cap | 46.19M |
|---|---|
| Shares Outstanding | 160.71M |
| Price to Book (P/B) | 1.61 |
| EV/EBITDA | -0.52 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Mereo BioPharma Group at a Glance
As of the Oct 22, 2026 close, Mereo BioPharma Group (MREO) has a market capitalization of $46.19M. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $30.12M in cash and securities against $1.03M of debt, a net cash position of $29.09M.
Mereo BioPharma Group does not currently pay a dividend.
The share price is down 85.6% over the past year. At $0.29 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $0.20 to $2.37, below its 200-day moving average of $0.34.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $3.00, 943.8% above the Oct 22, 2026 close.
Frequently Asked Questions About Mereo BioPharma Group
What is the current stock price for MREO?
As of the Oct 22, 2026 close, MREO stock trades at $0.29. The 52-week range is $0.20–$2.37, with a day range of $0.28–$0.29.
What is the P/E ratio for MREO?
The P/E ratio (Price-to-Earnings) for MREO is shown in the Key Statistics section. This valuation metric helps compare Mereo BioPharma Group plc to industry peers.
Does MREO pay dividends?
Mereo BioPharma Group does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MREO?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for MREO is Buy. The average 12-month price target is $3.00, a 943.8% upside from the Oct 22, 2026 close of $0.29.
What is the market cap of MREO?
As of the Oct 22, 2026 close, Mereo BioPharma Group's market capitalization is $46.2M, classifying it as a micro-cap company. Mereo BioPharma Group operates in the Healthcare sector within the Biotechnology industry.